U-PLEX Custom Metabolic Group 1 (hu) Assays
Closed Pre-Solicitation Posted
- Solicitation number
- 75N94025Q00224
- Agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Bethesda, Maryland, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health, is procuring U-PLEX Custom Metabolic Group 1 (hu) Assays through solicitation RFQ 75N94025Q00224. The procurement involves specialized assay kits containing specific analytes for research purposes, including U-PLEX plates for various metabolic markers such as FGF-21, Ghrelin, GIP, GLP-1, and PYY, which require two separate plates due to known sample incompatibilities. The government intends to make a direct award to the incumbent vendor based on their existing validated research protocols. Evaluation criteria will prioritize technical capability and past performance over price, with offerors required to submit specific representations and certifications. Quotations are due by September 9, 2025 at 12:00 PM and must be submitted via email to Kelly Robinson.
This opportunity is designated as a total small business set-aside under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing) with a size standard of 1,000 employees. Meso Scale Diagnostics, LLC in Rockville, Maryland appears to be the incumbent vendor that the government intends to award directly based on their validated research protocols. The contract calls for one assay kit (Catalog # K151ACM4) including shipping and handling, with delivery scheduled to Aaron Hengist at the Clinical Center in Bethesda, Maryland. The period of performance extends from September 15, 2025 to September 14, 2026, and the acquisition will be conducted using simplified acquisition procedures. The delivery location is specified as Building 10, 8th Floor, Wing C, Clinical Center, 10 Center Drive, Bethesda, MD 20814.
Notice text
For addtitional information please see the attached documents.
Files
| File | Type | Posted |
|---|---|---|
| 75N94025Q00224 (1).pdf | ||
| Combined synopsis.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity